drugset

drugset / Trial / NCT01508897

Comparison of Two Liraglutide Formulations in Healthy Volunteers

NCT01508897 ↗

Phase 1 Completed 22 enrolled Novo Nordisk A/S

RandomizedCrossoverSingle-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to test for bioequivalence of two formulations of liraglutide.

Timeline

Start: 2004-05-28
Primary completion: 2004-06-30
Completion: 2004-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Liraglutide	Peptide	—	Subcutaneous

Indications